Why XCath thinks it can win the stroke telesurgery race

XCath announced its Iris robotic telesurgical system for remote stroke treatment, claiming a competitive advantage after completing the first remote mechanical thrombectomy over 120 miles away. The system targets the stroke intervention market, where telesurgery capability could expand access to time-critical endovascular procedures beyond centers with on-site specialist availability.